Clorox Research Development vs Total Other Income Expense Net Analysis

CLX Stock

USD 160.45 2.64 1.67%

Clorox financial indicator trend analysis is way more than just evaluating Clorox prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Clorox is a good investment. Please check the relationship between Clorox Research Development and its Total Other Income Expense Net accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in The Clorox. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Research Development vs Total Other Income Expense Net

Research Development vs Total Other Income Expense Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Clorox Research Development account and Total Other Income Expense Net. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Clorox's Research Development and Total Other Income Expense Net is -0.15. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Other Income Expense Net in the same time period over historical financial statements of The Clorox, assuming nothing else is changed. The correlation between historical values of Clorox's Research Development and Total Other Income Expense Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of The Clorox are associated (or correlated) with its Total Other Income Expense Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Other Income Expense Net has no effect on the direction of Research Development i.e., Clorox's Research Development and Total Other Income Expense Net go up and down completely randomly.

Correlation Coefficient

-0.15

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Research Development

Total Other Income Expense Net

Most indicators from Clorox's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Clorox current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in The Clorox. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

At this time, Clorox's Tax Provision is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 24.87 in 2025, whereas Selling General Administrative is likely to drop slightly above 790.9 M in 2025.

	2022	2023	2024	2025 (projected)
Gross Profit	2.9B	3.0B	3.5B	2.1B
Total Revenue	7.4B	7.1B	8.2B	4.6B

Gross Profit Total Revenue

Clorox fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock Total Equity	Common Stock
Total Assets		0.97	0.41	0.77	0.12	0.92	0.94	0.11	0.2	0.99	0.82	0.2	0.89	-0.87	0.83	0.78	0.3	-0.04	0.98	0.35	0.94	-0.08	0.81	0.73	-0.91	-0.9
Short Long Term Debt Total	0.97		0.38	0.83	-0.05	0.88	0.97	0.16	0.18	0.96	0.73	0.18	0.95	-0.93	0.79	0.69	0.44	-0.14	0.99	0.28	0.93	0.1	0.78	0.61	-0.91	-0.9
Other Current Liab	0.41	0.38		0.47	-0.2	0.52	0.44	-0.46	-0.24	0.42	0.33	-0.24	0.41	-0.32	0.31	0.53	0.26	0.49	0.43	0.28	0.36	0.02	0.25	0.26	-0.49	-0.49
Total Current Liabilities	0.77	0.83	0.47		-0.34	0.71	0.81	0.0	0.12	0.74	0.57	0.12	0.83	-0.8	0.56	0.63	0.56	-0.05	0.84	0.19	0.78	0.5	0.59	0.43	-0.83	-0.83
Total Stockholder Equity	0.12	-0.05	-0.2	-0.34		-0.03	-0.11	0.41	0.24	0.15	0.21	0.24	-0.19	0.17	0.12	0.1	-0.69	-0.16	-0.07	-0.01	0.03	-0.51	0.36	0.55	0.16	0.16
Property Plant And Equipment Net	0.92	0.88	0.52	0.71	-0.03		0.87	-0.27	0.07	0.92	0.84	0.07	0.83	-0.73	0.8	0.82	0.31	0.32	0.91	0.53	0.86	-0.2	0.59	0.59	-0.88	-0.88
Net Debt	0.94	0.97	0.44	0.81	-0.11	0.87		0.06	-0.04	0.95	0.7	-0.04	0.95	-0.91	0.77	0.74	0.46	-0.06	0.97	0.32	0.84	0.1	0.77	0.56	-0.92	-0.91
Retained Earnings	0.11	0.16	-0.46	0.0	0.41	-0.27	0.06		0.43	0.09	-0.11	0.43	0.09	-0.28	-0.07	-0.32	-0.18	-0.96	0.09	-0.57	0.15	0.26	0.37	0.24	0.12	0.12
Cash	0.2	0.18	-0.24	0.12	0.24	0.07	-0.04	0.43		0.1	0.15	1.0	0.07	-0.16	0.12	-0.14	-0.09	-0.38	0.18	-0.16	0.46	-0.01	0.09	0.27	-0.01	-0.01
Non Current Assets Total	0.99	0.96	0.42	0.74	0.15	0.92	0.95	0.09	0.1		0.83	0.1	0.89	-0.85	0.84	0.81	0.27	-0.02	0.97	0.37	0.9	-0.1	0.83	0.74	-0.9	-0.9
Non Currrent Assets Other	0.82	0.73	0.33	0.57	0.21	0.84	0.7	-0.11	0.15	0.83		0.15	0.61	-0.53	0.76	0.8	0.07	0.24	0.77	0.35	0.75	-0.34	0.65	0.67	-0.72	-0.72
Cash And Short Term Investments	0.2	0.18	-0.24	0.12	0.24	0.07	-0.04	0.43	1.0	0.1	0.15		0.07	-0.16	0.12	-0.14	-0.09	-0.38	0.18	-0.16	0.46	-0.01	0.09	0.27	-0.01	-0.01
Net Receivables	0.89	0.95	0.41	0.83	-0.19	0.83	0.95	0.09	0.07	0.89	0.61	0.07		-0.91	0.75	0.65	0.42	-0.13	0.94	0.36	0.84	0.19	0.7	0.56	-0.9	-0.89
Common Stock Shares Outstanding	-0.87	-0.93	-0.32	-0.8	0.17	-0.73	-0.91	-0.28	-0.16	-0.85	-0.53	-0.16	-0.91		-0.61	-0.51	-0.47	0.31	-0.93	-0.1	-0.87	-0.24	-0.65	-0.48	0.84	0.83
Non Current Liabilities Total	0.83	0.79	0.31	0.56	0.12	0.8	0.77	-0.07	0.12	0.84	0.76	0.12	0.75	-0.61		0.88	0.28	0.11	0.8	0.67	0.76	-0.29	0.82	0.76	-0.88	-0.88
Inventory	0.78	0.69	0.53	0.63	0.1	0.82	0.74	-0.32	-0.14	0.81	0.8	-0.14	0.65	-0.51	0.88		0.25	0.4	0.73	0.66	0.66	-0.23	0.74	0.71	-0.87	-0.87
Other Current Assets	0.3	0.44	0.26	0.56	-0.69	0.31	0.46	-0.18	-0.09	0.27	0.07	-0.09	0.42	-0.47	0.28	0.25		0.01	0.43	0.05	0.35	0.44	0.17	-0.26	-0.5	-0.5
Other Stockholder Equity	-0.04	-0.14	0.49	-0.05	-0.16	0.32	-0.06	-0.96	-0.38	-0.02	0.24	-0.38	-0.13	0.31	0.11	0.4	0.01		-0.07	0.55	-0.1	-0.41	-0.28	-0.09	-0.11	-0.11
Total Liab	0.98	0.99	0.43	0.84	-0.07	0.91	0.97	0.09	0.18	0.97	0.77	0.18	0.94	-0.93	0.8	0.73	0.43	-0.07		0.31	0.95	0.05	0.75	0.62	-0.93	-0.93
Property Plant And Equipment Gross	0.35	0.28	0.28	0.19	-0.01	0.53	0.32	-0.57	-0.16	0.37	0.35	-0.16	0.36	-0.1	0.67	0.66	0.05	0.55	0.31		0.25	-0.4	0.27	0.45	-0.52	-0.53
Total Current Assets	0.94	0.93	0.36	0.78	0.03	0.86	0.84	0.15	0.46	0.9	0.75	0.46	0.84	-0.87	0.76	0.66	0.35	-0.1	0.95	0.25		0.0	0.69	0.65	-0.85	-0.85
Short Term Debt	-0.08	0.1	0.02	0.5	-0.51	-0.2	0.1	0.26	-0.01	-0.1	-0.34	-0.01	0.19	-0.24	-0.29	-0.23	0.44	-0.41	0.05	-0.4	0.0		-0.02	-0.27	-0.03	-0.02
Intangible Assets	0.81	0.78	0.25	0.59	0.36	0.59	0.77	0.37	0.09	0.83	0.65	0.09	0.7	-0.65	0.82	0.74	0.17	-0.28	0.75	0.27	0.69	-0.02		0.83	-0.75	-0.75
Accounts Payable	0.73	0.61	0.26	0.43	0.55	0.59	0.56	0.24	0.27	0.74	0.67	0.27	0.56	-0.48	0.76	0.71	-0.26	-0.09	0.62	0.45	0.65	-0.27	0.83		-0.63	-0.63
Common Stock Total Equity	-0.91	-0.91	-0.49	-0.83	0.16	-0.88	-0.92	0.12	-0.01	-0.9	-0.72	-0.01	-0.9	0.84	-0.88	-0.87	-0.5	-0.11	-0.93	-0.52	-0.85	-0.03	-0.75	-0.63		1.0
Common Stock	-0.9	-0.9	-0.49	-0.83	0.16	-0.88	-0.91	0.12	-0.01	-0.9	-0.72	-0.01	-0.89	0.83	-0.88	-0.87	-0.5	-0.11	-0.93	-0.53	-0.85	-0.02	-0.75	-0.63	1.0

Click cells to compare fundamentals

Clorox Account Relationship Matchups

Clorox fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	6.3B	6.2B	5.9B	5.8B	6.6B	4.0B
Short Long Term Debt Total	3.2B	3.1B	2.9B	2.9B	3.3B	1.8B
Other Current Liab	745M	509M	638M	536M	616.4M	316.9M
Total Current Liabilities	2.1B	1.8B	1.9B	1.6B	1.8B	1.3B
Total Stockholder Equity	411M	556M	220M	328M	295.2M	491.8M
Property Plant And Equipment Net	1.6B	1.7B	1.7B	1.7B	2.0B	995.6M
Net Debt	2.8B	2.9B	2.6B	2.7B	3.1B	1.6B
Retained Earnings	1.0B	1.0B	583M	250M	287.5M	273.1M
Cash	319M	183M	367M	202M	232.3M	247.6M
Non Current Assets Total	4.5B	4.4B	4.1B	4.1B	4.7B	2.8B
Non Currrent Assets Other	378M	315M	462M	269M	309.4M	241.9M
Cash And Short Term Investments	319M	183M	367M	202M	232.3M	247.6M
Net Receivables	604M	681M	688M	695M	799.3M	495.4M
Common Stock Shares Outstanding	127.3M	123.9M	124.2M	124.8M	112.3M	173.3M
Liabilities And Stockholders Equity	6.3B	6.2B	5.9B	5.8B	6.6B	4.0B
Non Current Liabilities Total	3.7B	3.6B	3.6B	3.7B	4.2B	4.4B
Inventory	752M	755M	696M	637M	732.6M	769.2M
Other Current Assets	154M	106M	77M	88M	101.2M	87.5M
Other Stockholder Equity	(210M)	(144M)	(1M)	102M	91.8M	96.4M
Total Liab	5.7B	5.4B	5.6B	5.3B	6.0B	3.3B
Property Plant And Equipment Gross	1.6B	1.3B	1.7B	4.5B	5.2B	5.4B
Total Current Assets	1.8B	1.7B	1.8B	1.6B	1.9B	1.2B
Accumulated Other Comprehensive Income	(546M)	(479M)	(493M)	(155M)	(139.5M)	(146.5M)
Short Term Debt	381M	315M	137M	88M	101.2M	96.1M
Intangible Assets	918M	884M	712M	681M	783.2M	849.6M
Accounts Payable	930M	960M	1.0B	950M	1.1B	1.1B
Other Liab	817M	901M	857M	832M	956.8M	709.4M
Other Assets	1.5B	378M	315M	462M	531.3M	557.9M
Long Term Debt	2.5B	2.5B	2.5B	2.5B	2.9B	2.0B
Property Plant Equipment	1.4B	1.6B	1.7B	1.7B	1.9B	1.2B
Good Will	1.6B	1.6B	1.3B	1.2B	1.4B	1.3B
Net Tangible Assets	(1.6B)	(2.1B)	(1.9B)	(1.7B)	(1.6B)	(1.5B)
Retained Earnings Total Equity	3.6B	1.0B	1.0B	583M	670.5M	636.9M
Capital Surpluse	1.1B	1.2B	1.2B	1.2B	1.4B	991.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

Additional Tools for Clorox Stock Analysis

When running Clorox's price analysis, check to measure Clorox's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clorox is operating at the current time. Most of Clorox's value examination focuses on studying past and present price action to predict the probability of Clorox's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clorox's price. Additionally, you may evaluate how the addition of Clorox to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Clorox Research Development vs Total Other Income Expense Net Analysis

Research Development vs Total Other Income Expense Net

Research Development vs Total Other Income Expense Net Correlation Analysis

Correlation Coefficient

Research Development

Total Other Income Expense Net

Clorox fundamental ratios Correlations

Clorox Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Clorox fundamental ratios Accounts

Also Currently Popular

Additional Tools for Clorox Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 1.0	Common Stock Total Equity
Non Current Assets Total	+ 0.99	Total Assets
Total Liab	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.98	Total Assets
Short Long Term Debt Total	+ 0.97	Total Assets

Other Stockholder Equity	- 0.96	Retained Earnings
Common Stock	- 0.93	Total Liab
Common Stock Total Equity	- 0.93	Total Liab
Total Liab	- 0.93	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.93	Short Long Term Debt Total
Common Stock Total Equity	- 0.92	Net Debt